Facebook Pixel

Inflammatory Bowel Disease (IBD) Program

The WakeMed Pediatric Inflammatory Bowel Disease (IBD) program is a highly specialized patient care program exclusively focused on providing comprehensive diagnostic and treatment services for children with IBD. Our team is dedicated to diagnosing and treating inflammatory bowel disease and we provide pediatric patients with comprehensive medical services.

Expert Care for Pediatric Inflammatory Bowel Disease

WakeMed Pediatric Inflammatory Bowel Disease program is made up of a team of experts in clinical care, surgery, radiology and pathology — all working together to help our patients with IBD. Our team approach ensures that every aspect of a patient’s care involves specialists from different disciplines, all experienced in the management of Crohn’s disease and ulcerative colitis to provide them access to our full range of services.

For example, during your child’s visit to the gastroenterologist, a pediatric surgeon may be available to discuss possible surgical options to treat your child’s condition. This allows you to see more than one subspecialist in one visit.

The IBD program's team of experts offers broad-based knowledge in every area of IBD treatment, including innovative immune-suppressing drug therapy such as Infliximab (Remicade) or Adalimumab (Humira). Leading pharmaceutical and biotechnology companies continually work with the expertise of our program’s clinicians regarding their new products and procedures.

little boy holding stomach

Infliximab (Remicade) Infusion Services

For the comfort and convenience of patients and families, our GI division provides outpatient Infliximab (Remicade) infusion services.  Your child does not have to go to the hospital to get this medication as it can be done at the very pleasant and comfortable outpatient setting of our practice.

Infliximab (Remicade) is a medication used to treat IBD. Infliximab (Remicade) helps decrease inflammation associated with inflammatory bowel disease by blocking an inflammatory chemical in the body. Infliximab (Remicade) is injected into a vein for 2 to 3 hours, a procedure called an infusion. This can be done in an outpatient setting at our Pediatric Gastroenterology practice. 

Infliximab (Remicade) is a very potent drug with the potential for side effects, which may occur during or after the infusion. Allergic reactions to the protein in Infliximab (Remicade) may be seen at any time during treatment. Therefore, it is important that we monitor patients.